Market open
$
164.66
Change
-0.27 -0.16%
Volume
Volume 835,017
Feb 2, 2023, 9:58 a.m.
Real time quotes
Previous close
$ 164.92
$ 164.66
Change
-0.27 -0.16%
Day low
Day high
$162.82
$164.67

52 week low
52 week high
$155.72
$186.69

Market cap
$431.18B
Average volume
7.04M
P/E ratio
24.34
Rev. per Employee
$670,028
EPS
6.74
Dividend
1.13
Div yield
2.76%
Ex dividend date
2/17/23
MarketWatch News on JNJ
-
Johnson & Johnson stock rises Wednesday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
These 20 stocks led the January rally
- Philip van Doorn
-
Johnson & Johnson stock rises Tuesday, still underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Pfizer Stock Falls on Downbeat Guidance
- Josh Nathan-Kazis
-
Johnson & Johnson Hit as Court Rejects Use of Bankruptcy in Talc Lawsuits
- Josh Nathan-Kazis
-
Johnson & Johnson stock falls Monday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Monday when compared to competitors
- MarketWatch Automation
-
Johnson & Johnson, Chevron share losses lead Dow's 261-point drop
- MarketWatch Automation
-
Dow's 169-point fall led by losses for shares of Johnson & Johnson, Chevron
- MarketWatch Automation
-
Johnson & Johnson stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Moderna Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
FDA Advisers Recommend Replacing All Covid Vaccines With Bivalent Version
- Josh Nathan-Kazis
-
Johnson & Johnson stock falls Thursday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock rises Thursday, still underperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
Analysts Are Overwhelmingly Bullish on Abbott Laboratories
- MarketRealist.com
-
Johnson & Johnson: Analyst Recommendations and Target Price
- MarketRealist.com
-
Wall Street’s Views on BSX’s Acquisition of Cryterion Medical
- MarketRealist.com
Other News on JNJ
-
Top 5 4th Quarter Trades of Alterity Financial Group, LLC
- GuruFocus.com
-
Core Alternative Capital's Top 5 Buys of the 4th Quarter
- GuruFocus.com
-
Exxon Vaults to Record Annual Profit of $55.7 Billion
- Collin Eaton
-
J&J Faces Longer Path to Resolving Talc Lawsuits
- Peter Loftus
-
Pfizer Expects Drop in Revenue as Vaccine Demand Wanes
- Jared S. Hopkins
-
Top 5 4th Quarter Trades of WAFRA INC.
- GuruFocus.com
-
5 Dividend King Stocks Gurus Are Feasting On
- GuruFocus.com
-
J&J’s Talc Bankruptcy Case Thrown Out by Appeals Court
- Jonathan Randles
-
How Biden Officials Bungled a Better Vaccine
- Allysia Finley
-
What CEOs Are Saying: ‘The Consumer Is Under Pressure’
- George Stahl
-
BALDWIN BROTHERS LLC/MA's Top 5 Buys of the 4th Quarter
- GuruFocus.com
-
Focused Investors LLC Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
Baillie Gifford Slashes Meta, Boosts Nvidia
- GuruFocus.com
-
Smith & Nephew Is Reverting to Fair Value
- GuruFocus.com
-
Top 5 4th Quarter Trades of ASSET MANAGEMENT CORP /IL/ /ADV
- GuruFocus.com
- Loading more headlines...
Press Releases on JNJ
-
Johnson & Johnson JNJ Pivots Trading Plans and Risk Controls
- Stock Traders Daily
-
Indicators in Picture for Next Week
- Baystreet.ca
-
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
- BusinessWire - BZX
-
Johnson & Johnson JNJ Trading Advice
- Stock Traders Daily
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com